Vaccine Development for Severe Fever with Thrombocytopenia Syndrome

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2021 Apr 30

PMID 33917632

Citations 12

Authors

Tomoki Yoshikawa

Affiliations

Soon will be listed here.

Abstract

Severe fever with thrombocytopenia syndrome (SFTS), which is caused by SFTS virus (SFTSV), is a tick-borne emerging zoonosis with a high case-fatality rate. At present, there is no approved SFTS vaccine, although the development of a vaccine would be one of the best strategies for preventing SFTS. This article focused on studies aimed at establishing small animal models of SFTS that are indispensable for evaluating vaccine candidates, developing these vaccine candidates, and establishing more practical animal models for evaluation. Innate immune-deficient mouse models, a hamster model, an immunocompetent ferret model and a cat model have been developed for SFTS. Several vaccine candidates for SFTS have been developed, and their efficacy has been confirmed using these animal models. The candidates consist of live-attenuated virus-based, viral vector-based, or DNA-based vaccines. SFTS vaccines are expected to be used for humans and companion dogs and cats. Hence for practical use, the vaccine candidates should be evaluated for efficacy using not only nonhuman primates but also dogs and cats. There is no practical nonhuman primate model of SFTS; however, the cat model is available to evaluate the efficacy of these candidate SFTS vaccines on domesticated animals.

Citing Articles

Recent research advances in the development of Dabie Banda virus vaccines.

Yu C, Lin Y, Dai Y, Wu B, Qi Z, Qian X PLoS Negl Trop Dis. 2024; 18(8):e0012411.

PMID: 39207951 PMC: 11361446. DOI: 10.1371/journal.pntd.0012411.

Knowledge mapping of severe fever with thrombocytopenia syndrome: a bibliometric analysis.

Zhang H, Zhang L Front Microbiol. 2024; 15:1423181.

PMID: 39139373 PMC: 11319145. DOI: 10.3389/fmicb.2024.1423181.

Analysis of early warning indicators of death in patients with severe fever with thrombocytopenia syndrome.

Yang M, Yin M, Hou B, Zhou L, Wang J, Zhao Z BMC Infect Dis. 2024; 24(1):765.

PMID: 39090556 PMC: 11293107. DOI: 10.1186/s12879-024-09599-0.

Potential mechanisms implied in tick infection by arboviruses and their transmission to vertebrate hosts.

Yuan C, Xu Q, Ning Y, Xia Q Integr Zool. 2024; 20(2):315-330.

PMID: 39016029 PMC: 11897945. DOI: 10.1111/1749-4877.12875.

A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses.

Lu J, Liu J, Wu Y, He X, Gao X, Chen X J Virol. 2024; 98(7):e0076924.

PMID: 38829138 PMC: 11265342. DOI: 10.1128/jvi.00769-24.

References

Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T . The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis. 2013; 209(6):816-27. PMC: 7107388. DOI: 10.1093/infdis/jit603. View

Ding Y, Liang M, Ye J, Liu Q, Xiong C, Long B . Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection. Clin Microbiol Infect. 2014; 20(11):O870-8. DOI: 10.1111/1469-0691.12636. View

Baicus A . History of polio vaccination. World J Virol. 2013; 1(4):108-14. PMC: 3782271. DOI: 10.5501/wjv.v1.i4.108. View

Hu J, Li S, Zhang X, Zhao H, Yang M, Xu L . Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome. Medicine (Baltimore). 2018; 97(22):e10848. PMC: 6392624. DOI: 10.1097/MD.0000000000010848. View

Choi Y, Park S, Sun Y, Yoo J, Pudupakam R, Foo S . Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis. Nat Microbiol. 2019; 4(3):429-437. PMC: 6548314. DOI: 10.1038/s41564-018-0329-x. View

Yamanaka A, Kirino Y, Fujimoto S, Ueda N, Himeji D, Miura M . Direct Transmission of Severe Fever with Thrombocytopenia Syndrome Virus from Domestic Cat to Veterinary Personnel. Emerg Infect Dis. 2020; 26(12):2994-2998. PMC: 7706950. DOI: 10.3201/eid2612.191513. View

Wyatt L, Earl P, Eller L, Moss B . Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci U S A. 2004; 101(13):4590-5. PMC: 384791. DOI: 10.1073/pnas.0401165101. View

Kenner J, Cameron F, Empig C, Jobes D, Gurwith M . LC16m8: an attenuated smallpox vaccine. Vaccine. 2006; 24(47-48):7009-22. PMC: 7115618. DOI: 10.1016/j.vaccine.2006.03.087. View

Yoshikawa T, Taniguchi S, Kato H, Iwata-Yoshikawa N, Tani H, Kurosu T . A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome. PLoS Pathog. 2021; 17(2):e1008859. PMC: 7886154. DOI: 10.1371/journal.ppat.1008859. View

10.

Brennan B, Rezelj V, Elliott R . Mapping of Transcription Termination within the S Segment of SFTS Phlebovirus Facilitated Generation of NSs Deletant Viruses. J Virol. 2017; 91(16). PMC: 5533932. DOI: 10.1128/JVI.00743-17. View

11.

Jin C, Jiang H, Liang M, Han Y, Gu W, Zhang F . SFTS virus infection in nonhuman primates. J Infect Dis. 2014; 211(6):915-25. DOI: 10.1093/infdis/jiu564. View

12.

Liu S, Chai C, Wang C, Amer S, Lv H, He H . Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev Med Virol. 2013; 24(2):90-102. PMC: 4237196. DOI: 10.1002/rmv.1776. View

13.

Kim K, Yi J, Kim G, Choi S, Jun K, Kim N . Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis. 2013; 19(11):1892-4. PMC: 3837670. DOI: 10.3201/eid1911.130792. View

14.

Yu X, Liang M, Zhang S, Liu Y, Li J, Sun Y . Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011; 364(16):1523-32. PMC: 3113718. DOI: 10.1056/NEJMoa1010095. View

15.

Kida K, Matsuoka Y, Shimoda T, Matsuoka H, Yamada H, Saito T . A Case of Cat-to-Human Transmission of Severe Fever with Thrombocytopenia Syndrome Virus. Jpn J Infect Dis. 2019; 72(5):356-358. DOI: 10.7883/yoken.JJID.2018.526. View

16.

Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W . Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A. 2012; 109(25):10053-8. PMC: 3382536. DOI: 10.1073/pnas.1120246109. View

17.

Yoshikawa R, Sakabe S, Urata S, Yasuda J . Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs. J Virol. 2019; 93(10). PMC: 6498056. DOI: 10.1128/JVI.02226-18. View

18.

Suder E, Furuyama W, Feldmann H, Marzi A, de Wit E . The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials. Hum Vaccin Immunother. 2018; 14(9):2107-2113. PMC: 6183239. DOI: 10.1080/21645515.2018.1473698. View

19.

Xu B, Liu L, Huang X, Ma H, Zhang Y, Du Y . Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 2011; 7(11):e1002369. PMC: 3219706. DOI: 10.1371/journal.ppat.1002369. View

20.

Park E, Shimojima M, Nagata N, Ami Y, Yoshikawa T, Iwata-Yoshikawa N . Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats. Sci Rep. 2019; 9(1):11990. PMC: 6700174. DOI: 10.1038/s41598-019-48317-8. View